WHAT’S NEW IN MEDICINE TODAY? 4 27 24WHAT’S NEW IN MEDICINE TODAY? 4 27 24
American Medicine Today - Radio
DR. ALFRED O. BONATI DISCUSSES THE LATEST DEVELOPMENTS IN USING STEM CELLS TO TREAT DEGENERATIVE EYE DISEASE.
9:29•27 Apr 2024
Stem Cells and Vision: Dr. Alfred O. Bonati's Breakthroughs in Eye Health
Episode Overview
- Stem cells offer hope for restoring vision in cases of degenerative eye disease.
- The discovery of the GDNF protein has shown promising results in correcting genetic eye issues.
- Animal trials have displayed significant vision restoration, leading to human trials in progress.
- Stem cells are directly introduced into the posterior part of the retina to regenerate damaged cells.
- Research focuses on intraocular damage and degenerative changes specific to the eye structure.
“The important thing is that recently was discovered a factor that irritate the glial cells and those ones will produce a protein. And that specific protein can correct the genetic problems on the eyes.”
Ever wondered if there’s hope for those suffering from degenerative eye diseases? In this fascinating episode of 'American Medicine Today', Dr. Alfred O. Bonati sheds light on the promising world of stem cell therapy for vision restoration. Dr. Bonati, known for his pioneering work, discusses how stem cells are being used to treat conditions that were once considered untreatable. He explains the science behind the GDNF protein and its revolutionary role in restoring sight.
From animal trials showing significant improvements to ongoing human trials, the potential for stem cell therapy in eye health is immense. Whether you're curious about medical innovations or directly affected by vision issues, this episode offers a glimpse into a brighter future. Tune in to hear about the latest advancements and what they could mean for those struggling with degenerative eye diseases.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.